M
TMO icon

Mirova’s Thermo Fisher Scientific TMO Stock Holding History

Mirova’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$36M Buy
73,275
+63,086
+619% +$34.2M 1.46% 18
2025
Q4 		$5.9M Sell
10,189
-9,779
-49% -$5.53M 0.85% 42
2025
Q3 		$9.68M Sell
19,968
-118,304
-86% -$55.1M 1.37% 20
2025
Q2 		$56.1M Sell
138,272
-13,179
-9% -$5.51M 7.91% 1
2025
Q1 		$75.4M Sell
151,451
-10,410
-6% -$5.64M 13.56% 1
2024
Q4 		$84.2M Buy
161,861
+2,390
+1% +$1.31M 14.53% 1
2024
Q3 		$98.6M Sell
159,471
-6,321
-4% -$3.74M 17.05% 1
2024
Q2 		$91.7M Sell
165,792
-49,229
-23% -$28.2M 16.75% 1
2024
Q1 		$125M Buy
215,021
+3,605
+2% +$2.02M 22.14% 1
2023
Q4 		$112M Buy
211,416
+1,012
+0.5% +$490K 22.98% 1
2023
Q3 		$107M Sell
210,404
-12,434
-6% -$6.63M 21.44% 1
2023
Q2 		$116M Sell
222,838
-43,642
-16% -$23.6M 20.46% 1
2023
Q1 		$154M Sell
266,480
-14,807
-5% -$8.35M 22.15% 1
2022
Q4 		$155M Sell
281,287
-10,748
-4% -$5.7M 24.25% 1
2022
Q3 		$148M Sell
292,035
-30,514
-9% -$17.1M 24.92% 1
2022
Q2 		$175M Buy
322,549
+257
+0.1% +$141K 24.9% 1
2022
Q1 		$190M Sell
322,292
-6,461
-2% -$3.71M 25.48% 1
2021
Q4 		$219M Buy
328,753
+6,037
+2% +$3.77M 26.27% 1
2021
Q3 		$184M Sell
322,716
-16,806
-5% -$9.22M 23.73% 1
2021
Q2 		$171M Hold
339,522
– – 20.53% 1
2021
Q1 		$155M Buy
339,522
+82,737
+32% +$39.5M 18.48% 1
2020
Q4 		$120M Sell
256,785
-10,175
-4% -$4.77M 15.38% 2
2020
Q3 		$118M Buy
266,960
+22,900
+9% +$9.46M 18.97% 1
2020
Q2 		$88.4M Buy
244,060
+11,587
+5% +$3.88M 20.3% 1
2020
Q1 		$65.9M Buy
232,473
+27,613
+13% +$8.71M 24.95% 1
2019
Q4 		$66.6M Sell
204,860
-167,543
-45% -$50.8M 23.16% 1
2019
Q3 		$108M Sell
372,403
-59,046
-14% -$16.9M 13.37% 1
2019
Q2 		$127M Buy
431,449
+301,038
+231% +$82.9M 11.2% 1
2019
Q1 		$35.7M Sell
130,411
-24,614
-16% -$6.13M 19.35% 1
2018
Q4 		$34.7M Buy
+155,025
New +$36.4M 15.86% 1

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Mirova's TMO Position: Q1 2026 in Review

Mirova increased its Thermo Fisher Scientific (TMO) stake by 619% in Q1 2026, buying an estimated $34.2M and bringing the position to 73,275 shares worth $36M. The position accounts for 1.46% of the portfolio, ranked #18.

Mirova first reported a position in TMO in Q4 2018 and has held it in 30 quarters since. The position peaked at $219M in Q4 2021. 2,589 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Mirova held 73,275 shares of Thermo Fisher Scientific worth $36M as of Q1 2026.
  • Mirova bought 63,086 Thermo Fisher Scientific shares in Q1 2026, an estimated $34.2M.
  • Thermo Fisher Scientific made up 1.46% of Mirova's portfolio in Q1 2026, its #18 holding.
  • Mirova first reported a position in Thermo Fisher Scientific in Q4 2018 and has held it in 30 quarters since.
  • Mirova's Thermo Fisher Scientific position peaked at $219M in Q4 2021.
  • 2,589 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Mirova's 13F filing for Q1 2026, filed 14 May 2026.